State of chromosome 3q27 and different subtypes of diffuse large B-cell lymphoma and their prognostic correlation

Chinese Journal of Pathology

Volumn 38, Issue 4, 2009, Pages 231-236

  Yi, Li ^a   Gao ping, Wang ^a   Yan frn, Xi ^a   Jin feng, Wang ^a,b   Wei, Bal ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b SHANXI TUMOR HOSPITAL   (China)

Author keywords

Chromosomes,human,pair 3; Immunophenotype; Lymphoma,large cell,diffuse; Prognosis; Proto oncogene protein c bcl 6

Indexed keywords

CD20 ANTIBODY; CD3 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; INTERFERON REGULATORY FACTOR 4; PARAFFIN; PROTEIN BCL 6;

ALGORITHM; ARTICLE; B LYMPHOCYTE; CHROMOSOME 3Q; CHROMOSOME 3Q27; CHROMOSOME BREAKAGE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE EXPRESSION; GENETICS; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; FOLLOW-UP STUDIES; GERMINAL CENTER; HUMANS; IMMUNOPHENOTYPING; INTERFERON REGULATORY FACTORS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEPRILYSIN; PROTO-ONCOGENE PROTEINS C-BCL-6; SURVIVAL RATE; YOUNG ADULT;

EID: 67649378827     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/crna.j.issn.0529-5807.2009.04.004     Document Type: Article

References (29)

1. Hunt KE, Reiehard KK. Diffuse large B-cell lymphoma. Arch Pathol Lab Mcd, 2008, 132(1) :118-124.
2. Cniflier B. Diffuse large cell lymphoma. Cuff Opin Oncol, 2001, 13(5) :325-334.
3. Hans CP, Weisenberger D, Greiner TC, et al. Confinnation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarry. Blood, 2003, 103 (1) :275-282.
4. Chinese Source
5. Lossos IS, Czerwinski DK, Alizadeb AA, et al. Prediction of survival in diffuse large B-cell lymphoma based on the expression of six genes. N Engl J Med, 2004, 350(18) :1828-1837.
6. Offit K, Le Coco F, Louie DC, et al Rearrangement of the BCE-ri gene as a prognostic marker in diffuse large cell lymphoma. N Engl J Med, 1994, 331(2) :74.80.
7. Chinese Source
8. Ueda C, Akasaka T, Ohno H. Non-immunoglobulin/BCL6 gene fusion in diffuse large B-cell lymphoma: prognostic implications. Leuk Lyrnphoma, 2002, 43(7) :1375-1381.
9. Ohno H. Pathogenetic and clinical implications of nonimmunoglobulin; BCL.6 translocations in B-cell non-Hodgkin' lymphoma. I Clin Exp Hematop, 2006, 46(2) :43-53.
10. Akaaaka T, Ueda C, Kurata M, et al. Nonimmunoglohulin (nonIg)/BCL-6 gene fusion in diffuse large B-cell lymphoma results in worse prognosis than lg/BCL-6. Blood, 2000, 96 (8) : 2907-2909.
11. Sjö LD, Poulsen CB. Profiling of diffuse large B-cell lymphoma by immunohistochemistry: identification of prognostic subgroups. Eur J Haematol, 2007, 79(7) :501-507.
12. Chinese Source
13. Steven H, Campo E, Harris NE, et al World Health Organization classification of tumours. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2008: 233-237.
14. Petersen BE, Sqsrensen MC, Pedersen 5, et al. Fluorescence in situ hybridization on formalin-fixed and paraffin-enthedded tissue: Optimizing the method. Appl Immunohistochem Mol Morphol, 2004, 12(3) :259-265.
15. Rosenwald A, Wright G, Chen WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large B- cell lymphoma. N EngI 3 Med, 2002, 346(25) :1937-1947.
16. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B cell lymphoma identified by gene expression profiling. Nature, 2000, 403(6769) :503-511.
17. Colomo L, Løpez-Guillenno A, Perales M, et al. Clinical impact of the differentiation profile assessed by immumophenotyping in patients with diffuse large B-cell lymphoma. Blood, 2003, 101 (1) :78-84.
18. Fabiani B, Delmer A, Lepage E, et al. CDIO expression in diffuse large B-cell lymphoma dose not influence survival. Virchows Arch, 2004, 445(6) :545-551.
19. Parekh 5, Polo 3M, Shaknovich R, ci al. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms. Blood, 2007, 110(6) :2067-2074.
20. Choi WWL, Weisenburger DD, Greiner TC, et al. A New Immunoatain Algorithm Improves the Classification of Diffuse Large B-Cell Lymphoma into Prognostically Significant Subgroups. United States and Canadian Academy of Pathology ( USCAP), 2008 Annual Meeting, Denver Colorado, 2008 March 3: 1144-1146. ( http://www.ahstracts2view.com/uscap08/view.php?nu=USCAPO8L-1 144).
21. Bastard C, Till H, Lenonnand B, et al. Translocatione involving band 3q27 and Ig gene regions in non-Hodgkin' s lymphoma. Blood, 1992, 79(10):2527-253l.
22. Le Coco F, Ye BH, Lista F, et al. Rearrangement of the BCL6 gene in diffuse large cell lyrophoma. Blood, 1994, 83(7) :1757 1759.
23. Depaepe P, Achten R, Verhoef G, et al. Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B cell lymphomas. J Clin Oncol, 2005, 23(28) :7060-7068.
24. Barrans SE, O'Connor SI, Evans PA, et al. Rearrangement of the BCL.6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B cell lymphoma. Br I Haematol, 2002, 117 (2) :322-332.
25. Chen W, Lida 5, Louie DC, et al. Heterologous promoters fused to BCI-6 by chromosomal tranalocations affecting band 3q27 cause its deregulated expression during B-cell differentiation. Blood, 1998, 91(2) :603-607.
26. Chinese Source
27. Jerkeman M, Aman P, Cavallin-Stahl E, et al. Prognostic implications of BCL.6 rearrangement in uniformly treated patients with diffuse large B cell lymphoma a Nordic Lymphoma Group study. Intl Oncol, 2002, 20(1) :161-165.
28. Wilson W, Dunleavy K, Pittaluga 5, et al. Phase II study of dose-adjusted EPOCH-Rituximab in Untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers. 3 Clin Oncol, 2008, 26(16) :2717-2724.
29. Nyman H, Adde M, Karjalainen-Lindsberg ML, et al. Prognostic impact of immunohiatochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy. Blood ,2007 ,109(11) :4930-4935.